Guidelines for the Diagnosis and Treatment of Urticaria and Angioedema

  • Hide Michihiro
    Department of Dermatology, Programs for Biomedical Research, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University
  • Furue Masutaka
    Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
  • Ikezawa Zenro
    Department of Enviromental Immuno-Dermatology, Yokohama City University Graduate School of Medicine
  • Shiohara Tetsuo
    Department of Dermatology, Kyorin University School of Medicine
  • Furukawa Fukumi
    Department of Dermatology, School of Medicine, Wakayama Medical University
  • Matsunaga Kayoko
    Department of Dermatology, Fujita Health University School of Medicine
  • Nagano Takuzo
    Nagano Dermatological Clinic
  • Oji Masataka
    Oji Dermatological Clinic
  • Horikawa Tatsuya
    Division of Dermatology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine
  • Kameyoshi Yoshikazu
    Department of Dermatology, Programs for Biomedical Research, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University
  • Kitajima Yasuo
    Department of Dermatology, Gifu University School of Medicine

Bibliographic Information

Other Title
  • 蕁麻疹・血管性浮腫の治療ガイドライン
  • 生涯教育講座 蕁麻疹・血管性浮腫の治療ガイドライン
  • ショウガイ キョウイク コウザ ジンマシン ケッカンセイ フシュ ノ チリョウ ガイドライン

Search this article

Abstract

Guidelines for the treatment of urticaria and angioedema have been prepared by the Japanese Dermatological Association. Subtypes of urticaria and angioedema have been classified into large three groups from the viewpoint of examinations and treatments; I. idiopathic urticaria, II. urticaria inducible by particular stimuli, and III. special types of urticaria and urticaria pigmentosa. The use of oral histamine H1-receptor antagonists is the first line treatment, regardless of the group, provided that sufficient efforts to eliminate the cause and/or aggravating factors are taken. Several options for treatment are suggested as second and/or third line treatments, but the aim of examinations and treatments should be determined by the type and severity of the disease.

Journal

Citations (45)*help

See more

References(14)*help

See more

Details 詳細情報について

Report a problem

Back to top